Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lce1l Inhibitors

Lce1l inhibitors constitute a unique class of chemical compounds that are specifically engineered to interact with the Lce1l protein. This protein is a part of the Late Cornified Envelope (Lce) protein family, which plays a crucial role in the physiology of the skin, particularly in the formation and maintenance of the cornified envelope, a key structure in the skin's outermost layer. The Lce1l protein, similar to other members of its family, is noted for its specific expression patterns, predominantly found in the epidermal layers of the skin. The development of inhibitors targeting the Lce1l protein involves intricate and precise molecular engineering, aiming to achieve a targeted and effective interaction with this specific protein. This process entails a deep understanding of the molecular structure and biological role of Lce1l, which is fundamental in the design and synthesis of these inhibitory compounds.

The creation of Lce1l inhibitors is a sophisticated endeavor, encompassing advanced techniques in medicinal chemistry and molecular biology. It begins with an in-depth analysis of the molecular structure of the Lce1l protein. Understanding this structure is essential for developing inhibitors that are both effective and highly specific to their target. The interaction between Lce1l inhibitors and the Lce1l protein is a focal point of research. This interaction is characterized by the inhibitor binding to specific sites on the protein, necessitating an exact alignment of molecular structures. Often, this interaction involves the formation of hydrogen bonds and other molecular forces. The design process for Lce1l inhibitors also considers factors like the compound's stability, solubility, and its ability to reach the target site within biological systems. This process requires a careful balance of hydrophobic and hydrophilic properties of the compound, as well as considerations for its overall molecular size and shape. Such detailed and precise design processes demonstrate the complexity and specificity necessary for targeting specific proteins effectively, underscoring the advanced level of current research in biochemistry and pharmacology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

A compound that binds to DNA and inhibits RNA polymerase, thus can block RNA synthesis and potentially downregulate gene expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

A potent inhibitor of RNA polymerase II, which is essential for mRNA synthesis, potentially leading to decreased gene expression.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

A selective inhibitor of RNA polymerase II, potentially resulting in the inhibition of mRNA synthesis and gene expression.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

A compound known to inhibit the transcription of various genes by affecting the activity of RNA polymerase II.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

A cyclin-dependent kinase inhibitor that can prevent cell cycle progression and may affect overall gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor that changes chromatin structure and can alter gene expression patterns.

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$100.00
$200.00
13
(1)

A natural compound that inhibits histone acetyltransferases, potentially affecting transcription and gene expression.

Mitoxantrone

65271-80-9sc-207888
100 mg
$279.00
8
(1)

A type II topoisomerase inhibitor that can also intercalate into DNA, affecting its transcriptional activity.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

An inhibitor of DNA topoisomerase I, necessary for DNA replication and transcription processes.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

A compound that can inhibit bacterial RNA polymerase, and at certain concentrations, also affect mammalian RNA polymerase activity.